期刊文献+

硫堇褪色光度法测定微量肝素 被引量:1

COLOR-FADING-PHOTOMETRIC DETERMINATION OF MICROAMOUNTS OF HEPARIN
下载PDF
导出
摘要 在pH4.10的Britton-Robinson缓冲溶液中,肝素与碱性吩噻嗪染料硫堇形成离子缔合物时,染料发生明显的褪色。体系吸光度的降低与肝素钠浓度成正比,肝素的质量浓度在0~60μg/25mL范围内符合比耳定律,摩尔吸光系数为3.58×10^6L·mol^-1·cm^-1。研究了表面活性剂和共存物质的影响,表明方法选择性好。用于肝素钠注射液效价的测定,相对标准偏差小于3%,回收率为96.5%~101.9%。 In a BR buffer solution of pH 4. 10, an ion association complex was formed between heparin and thionine, resulting the color-fading of the basic dye, thionine. Decrease of the intensity of absorbance of thionine was found to be directly proportional to the concentration of heparin in the range of 0-60μg/25 mL. The value of molar absorptivity was found to be 3. 58×10^6L·mol^-1·cm^-1. Effects of surfactants and co-existing substances were studied, and the results obtained showed its acceptable selectivity. The proposed method has been applied to the determination of potency of heparin injection liquor, giving RSD's less than 3%, and recoveries in the range of 96. 5%-101.9%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2006年第10期829-831,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
关键词 褪色光度法 肝素 硫堇 Color-fading photometry Heparin Thionine
  • 相关文献

参考文献6

二级参考文献6

共引文献65

同被引文献38

  • 1谢继青,牛爱军,方喜峰,程霞,张妍,喻学红.低分子肝素舌下含片处方筛选及其药效观察[J].中国医院药学杂志,2004,24(10):590-592. 被引量:5
  • 2徐红,席晓岚.派罗宁B褪色光度法测微量肝素[J].化学与生物工程,2006,23(2):57-59. 被引量:2
  • 3沈腾,徐惠南,翁伟宇,张建芳,高璇.低分子肝素肠道吸收促进剂的研究[J].中国药学杂志,2006,41(3):206-210. 被引量:5
  • 4Kim SK, Lee EH, Vaishali B, et al.Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates[J]. J Control Release, 2005, 105 (1-2) : 32-42.
  • 5Hoffart V, Lamprecht A, Maincent P, et al. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system [J]. J Control Release, 2006, 113 (1) : 38-42.
  • 6Arnold J, Ahsan F, Meezan E, Pillion DJ, et al. Nasal administration of low molecular weight heparin [J]. J Pharm Sci, 2002, 91 (7): 1707-1714.
  • 7Yang T, Hussain A, Paulson J, et al. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies [J]. Pharm Res, 2004, 21 (7) : 1127-1136.
  • 8Yang T, Mustafa F, Ahsan F. Alkanoylsucroscs in nasal delivery of low molecularweight heparins: in-vivo absoinption and reversibility studies in rats [J]. J Pharm Pharmacol, 2004, 56(1): 53-60.
  • 9Rawat A, Majumder QH, Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation [J]. J Control Release, 2008, 128 (3):224-232.
  • 10Qi Y, Zhao G, Liu D, et al. Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route [J]. Proc Natl Acadc Sci USA, 2004, 101 (26) : 9867-9872.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部